FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Primidone Tablets
Status: Discontinuation
»Therapeutic Categories: Neurology

Expand all

Par Pharmaceuticals/Qualitest (New 11/09/2017)

Company Contact Information:
800-828-9393, option 5, then option 2

Presentation Posting Date Related Information
Primidone Tablets 50 mg 100 (NDC 00603-5371-21) 11/09/2017
Primidone Tablets 50 mg 500 (NDC 00603-5371-28) 11/09/2017
Primidone Tablets 250 mg 100 (NDC 00603-5372-21) 11/09/2017
Primidone Tablets 250 mg 500 (NDC 00603-5372-28) 11/09/2017

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English